Ophthalmoplegia Market
The report for the global ophthalmoplegia
market by Market
Research Future comprises of extensive primary research along with the
detailed analysis of qualitative as well as quantitative aspects by various
industry experts, key opinion leaders to gain a deeper insight of the market
and industry performance.
The global ophthalmoplegia
market is expected to grow at a CAGR of ~ 7.2 % during the forecast
period 2017-2023.
Ophthalmoplegia, also referred as extra
ocular muscle palsy, is a paralysis of the extra ocular muscles that control
movements of eyes. In this condition, nerve fibers that coordinate both eyes in
horizontal movements looking from side to side- are damaged. A number of
devices and treatments are available in the market, which can cure or improve
the eyesight of the patient. The Global ophthalmoplegia
market is driven by increasing number of people with ophthalmoplegia and
increasing geriatric population. According to the World Health Organization in
2010, about 250 million people of over 50 years were suffering from visual
impairment. Around 80% people in many of the developing countries have eye
sight problems; of which nearly 50% of the people are not able to take
treatment due to huge cost of the surgeries. Increasing prevalence of eye sight
affecting diseases, for instance, diabetes and rapid developments in technology
have fuelled the growth of the market. On the other hand, high cost of the
treatment and availability of cheap alternative treatment may slow the growth
of the market.
Top Key Players: Abbott
(US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant
Pharmaceuticals International, Inc. (US), Amritt, Inc. (US), Medline
Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson
(US).
Get
Sample copy at https://www.marketresearchfuture.com/sample_request/4216
.
Segments
The global ophthalmoplegia market has been segmented on the basis of type, treatment and end user.
Segments
The global ophthalmoplegia market has been segmented on the basis of type, treatment and end user.
On the
basis of types, the market is segmented into external ophthalmoplegia and
internuclear ophthalmoplegia. External ophthalmoplegia is further segmented
into superior recti, inferior recti, medial recti, lateral recti, inferior
oblique, and superior oblique muscles.
On the
basis of treatment, the market is segmented into surgery, drug treatment, and
others. The surgery is further segmented into strabismus surgery and others.
On the
basis of end users, the market is segmented into hospital & clinics, ambulatory
clinics, and others.
Regional analysis
The Americas dominates the global ophthalmoplegia market owing to well-developed technology and increased patient population with eye sight problem primarily due to increasing prevalence of diabetes. Additionally, high healthcare expenditure and the presence of some of the leading players have fuelled the growth of the market in this region.
Europe is
the second largest ophthalmoplegia market,
which is followed by Asia Pacific. Increasing government support and
availability of funds for research drive the growth of the market. Asia Pacific
is the fastest growing ophthalmoplegia
market due to increasing geriatric population and rapidly developing
medical sector.
On the
other hand, the Middle East & Africa holds the least share of the market
due to limited availability of medical facilities and poor economic and
political conditions in Africa.
The
report gives a clear picture of the current market scenario which includes past
and estimated future market size with respect to value and volume,
technological advancement, macro economical and governing factors in the
market. The report provides detail information about and strategies used by top
key players in the industry. The report also gives a broad study of the
different market segments and regions.
Brief
TOC
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
…Continued
Get Discount
at https://www.marketresearchfuture.com/check-discount/4216
.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment